17 Nov 08 Bone Marrow Toxicity In Advanced Lung Cancer May Be Reduced By Proton Therapy And Concurrent Chemotherapy
Patients treated for locally advanced non-small cell lung cancer who receive chemotherapy and proton beam therapy have fewer instances of bone marrow toxicity than patients who receive the standard treatment of intensity-modulated radiation (IMRT) and concurrent chemotherapy, according to researchers from The University of Texas M. D. Anderson Cancer Center.
(more…)
Tags: Anderson Cancer Center, Bone Cancer, Bone Marrow Toxicity, Cancer Chemotherapy, Cancer Therapy, Cell Lung Cancer, Chemotherapy, Chemotherapy Patients, Imrt, Instances, Intensity Modulated Radiation, Lung Cancer, M D Anderson, M D Anderson Cancer Center, Non Small Cell Lung Cancer, Proton Beam Therapy, Proton Therapy, Small Cell Lung Cancer, University Of Texas, University Of Texas M D Anderson Cancer Center
20 Oct 08 Women With Aggressive HER2 Positive Breast Cancer May Miss Out On Chemotherapy And Trastuzumab (Herceptin®)
Women with a particularly aggressive form of early stage (primary) breast cancer may miss out on optimal treatment which may include chemotherapy and trastuzumab (Herceptin) as a result of untimely or missing HER2-status test results, according to doctors responding to the results from a North of England Cancer Network audit of HER2-testing today.
(more…)
Tags: Breast Cancer, Cancer Chemotherapy, Cancer Network, Cancer Treatment, Chemotherapy, Doctors, Her2 Positive Breast Cancer, Herceptin, Network Audit, North England, North Of England, Optimal Treatment, Test Results, Women Breast
20 Oct 08 Women With Aggressive HER2 Positive Breast Cancer May Miss Out On Chemotherapy And Trastuzumab (Herceptin®)
Women with a particularly aggressive form of early stage (primary) breast cancer may miss out on optimal treatment which may include chemotherapy and trastuzumab (Herceptin) as a result of untimely or missing HER2-status test results, according to doctors responding to the results from a North of England Cancer Network audit of HER2-testing today.
(more…)
Tags: Breast Cancer, Cancer Chemotherapy, Cancer Network, Cancer Treatment, Chemotherapy, Doctors, Her2 Positive Breast Cancer, Herceptin, Network Audit, North England, North Of England, Optimal Treatment, Test Results, Women Breast
07 Oct 08 Alternatives For Radiation Of Low-Grade Brain Tumors Found By Pediatric Study
A multi-institutional study led by researchers at The University of Texas M. D. Anderson Cancer Center has found that using chemotherapy alone and delaying or avoiding cranial radiation altogether can be effective in treating pediatric patients with unresectable or progressive low-grade glioma. The study was presented at the 40th annual International Society of Pediatric Oncology Meeting in Berlin, Germany. Low-grade glioma is the most common brain tumor in children.
(more…)
Tags: Anderson Cancer Center, Berlin Germany, Brain Tumor, Brain Tumors, Cancer Chemotherapy, Chemotherapy, Institutional Study, Led, Low Grade Glioma, M D Anderson, M D Anderson Cancer Center, Meeting In Berlin, Oncology, Pediatric Oncology, Pediatric Patients, Pediatric Study, Progressive, Radiation, University Of Texas, University Of Texas M D Anderson Cancer Center
30 Sep 08 Risk For Pancreatic Cancer May Be Increased By Hepatitis B Exposure
In a first-of-its-kind finding, researchers at The University of Texas M. D. Anderson Cancer Center have discovered that exposure to the hepatitis B virus (HBV) may increase the risk of pancreatic cancer. The study, published in the Oct. 1 edition of the Journal of Clinical Oncology, also suggests that patients with this lethal form of cancer treated with chemotherapy may face danger of reactivation of their HBV.
(more…)
Tags: Anderson Cancer Center, Cancer Chemotherapy, Chemotherapy, Face, Hbv, Hepatitis, Hepatitis B, Hepatitis B Virus, Hepatitis Virus, Journal Of Clinical Oncology, M D Anderson, M D Anderson Cancer Center, Oncology, Pancreatic Cancer, Reactivation, Risk, University Of Texas, University Of Texas M D Anderson Cancer Center
17 Sep 08 Survival In Early Breast Cancer Improved By Adding Taxotere To Chemotherapy Regimen
For patients with early stage breast cancer that has spread to the lymph nodes, adding four cycles of docetaxel (Taxotere) into a sequential regimen of epirubicin followed by cyclophosphamide, methotrexate and fluorouracil (CMF) reduces the risk of recurrence and death, updated long-term results show.
(more…)
Tags: Breast Cancer, Cancer Chemotherapy, Chemotherapy, Cmf, Docetaxel, Epirubicin, Fluorouracil, Lymph Nodes, Methotrexate, Recurrence, Regimen, Risk, Stage Breast Cancer, Survival, Taxotere
17 Sep 08 New Drug Substantially Extends Survival In Pancreatic Cancer
A new form of chemotherapy that destroys new blood vessels that grow around tumors has produced excellent results in a phase II trial of patients with inoperable pancreatic cancer, researchers report at the 33rd Congress of the European Society for Medical Oncology (ESMO) in Stockholm. European investigators led by Prof.
(more…)
Tags: Blood Vessels, Cancer Chemotherapy, Cancer Researchers, Chemotherapy, Congress, Esmo, Investigators, Medical Oncology, New Blood, Oncology, Pancreatic Cancer, Phase Ii, Stockholm, Survival, Tumors
